Employees: 12 (2023.0)Legal category: 5485Size: PMECreation date: 2017-02-24 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: ABBEVILLE (80100), Somme
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE L'EUROPE : revenue, balance sheet and financial ratios
PHARMACIE DE L'EUROPE is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in ABBEVILLE (80100),
this company of category PME
shows in 2025 a net income positive of 476 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE L'EUROPE (SIREN 827952987)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
475 525 €
598 114 €
642 557 €
403 936 €
281 356 €
74 702 €
294 186 €
221 082 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE L'EUROPE generates positive net income of 476 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2018-2025: 221 k€ -> 476 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
475 525 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 136%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 33%. The balance between equity and debt is satisfactory.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
136.392%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
33.028%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE DE L'EUROPE
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
278.176
208.151
242.79
220.707
395.695
245.0
175.057
136.392
Financial autonomy
22.829
28.074
23.946
25.048
15.844
22.611
28.218
33.028
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
136.392025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Average
In 2025, the debt ratio of PHARMACIE DE L'EUROPE (136.39) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
33.03%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Average
In 2025, the financial autonomy of PHARMACIE DE L'EUROPE (33.0%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 144.21. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
144.213
Liquidity indicators evolution PHARMACIE DE L'EUROPE
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
180.237
162.561
117.601
154.03
135.807
136.936
141.731
144.213
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
144.212025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Average+5 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE L'EUROPE (144.21) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE DE L'EUROPE in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE L'EUROPE is estimated at
7 553 771 €
(range 5 126 024€ - 11 852 907€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
5126k€7553k€11852k€
7 553 771 €Range: 5 126 024€ - 11 852 907€
NAF 5 année 2025
Valuation method used
Net Income Multiple
475 525 €
×
15.9x
=7 553 771 €
Range: 5 126 025€ - 11 852 907€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE L'EUROPE with other companies in the same sector:
Frequently asked questions about PHARMACIE DE L'EUROPE
What is the revenue of PHARMACIE DE L'EUROPE ?
The revenue of PHARMACIE DE L'EUROPE is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE L'EUROPE profitable?
Yes, PHARMACIE DE L'EUROPE generated a net profit of 476 k€ in 2025.
Where is the headquarters of PHARMACIE DE L'EUROPE ?
The headquarters of PHARMACIE DE L'EUROPE is located in ABBEVILLE (80100), in the department Somme.
Where to find the tax return of PHARMACIE DE L'EUROPE ?
The tax return of PHARMACIE DE L'EUROPE is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE L'EUROPE operate?
PHARMACIE DE L'EUROPE operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart